paper-with-me

홈 › Papers

KinetiDiff: Docking-Guided Diffusion for De Novo ACVR1 Inhibitor Design in Fibrodysplasia Ossificans Progressiva

2026-04-17 · Aaryan Patel arxiv

We present KinetiDiff, a structure-based framework for de novo kinase inhibitor design that integrates a Geometry-Complete Diffusion Model with real-time AutoDock Vina gradient guidance. By injecting physics-based docking gradients into the diffusion denoising loop, KinetiDiff steers molecule generation toward high-affinity conformations for ACVR1 (ALK2), the causative kinase in Fibrodysplasia Ossificans Progressiva. From 10,000 diffusion samples, the framework produced 9,997 valid molecules. The best candidate achieved $-11.05$ kcal/mol (pKd = 8.10), a 19.2% improvement over the crystallographic reference. The top 100 candidates all exceed the reference, with 100% Lipinski compliance, median synthetic accessibility of 2.67, and internal diversity of 0.790. Systematic ablation across four guidance strategies--Vina-Direct (physics), HNN-Denovo (neural proxy), multi-objective, and unguided--demonstrates that real-time docking guidance dominates on all metrics. We evaluate HNN-Denovo as a computationally efficient alternative (60-fold speedup per step), revealing a domain-mismatch limitation (r = 0.224 correlation with Vina) that explains its inferior performance. These results establish gradient-guided geometric diffusion as a practical approach for generating potent, synthetically accessible inhibitors against rare-disease kinase targets.

📄 PDF Abstract BibTeX arXiv:2604.20886

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

MagicDock: Toward Docking-oriented De Novo Ligand Design via Gradient Inversion

2025-10-10 · Zekai Chen, Xunkai Li, Sirui Zhang, Henan Sun 외 arxiv

De novo ligand design is a fundamental task that seeks to generate protein or molecule candidates that can effectively dock with protein receptors and achieve strong binding affinity entirely from scratch. It holds param…

Structure-aware generation of drug-like molecules

2021-11-07 · Pavol Drotár, Arian Rokkum Jamasb, Ben Day, Cătălina Cangea 외

Structure-based drug design involves finding ligand molecules that exhibit structural and chemical complementarity to protein pockets. Deep generative methods have shown promise in proposing novel molecules from scratch …

Drug Design

Navigating the Design Space of Equivariant Diffusion-Based Generative Models for De Novo 3D Molecule Generation

2023-09-29 · Tuan Le, Julian Cremer, Frank Noé, Djork-Arné Clevert 외

Deep generative diffusion models are a promising avenue for 3D de novo molecular design in materials science and drug discovery. However, their utility is still limited by suboptimal performance on large molecular struct…

3D Molecule GenerationDrug DiscoveryUnconditional Molecule Generation

Diffusion Models in $\textit{De Novo}$ Drug Design

2024-06-07 · Amira Alakhdar, Barnabas Poczos, Newell Washburn

Diffusion models have emerged as powerful tools for molecular generation, particularly in the context of 3D molecular structures. Inspired by non-equilibrium statistical physics, these models can generate 3D molecular st…

Computational chemistryDenoisingDrug DesignDrug Discovery+1

Regressor-guided Diffusion Model for De Novo Peptide Sequencing with Explicit Mass Control

2026-02-23 · Shaorong Chen, Jingbo Zhou, Jun Xia arxiv

The discovery of novel proteins relies on sensitive protein identification, for which de novo peptide sequencing (DNPS) from mass spectra is a crucial approach. While deep learning has advanced DNPS, existing models inad…